NCT01042132

Brief Summary

To what extent the cardiopulmonary and inflammatory response is affected by initial femoral intramedullary nailing in the already traumatized and inflammatory activated patient was analyzed in the present study with the attention to survey the additional burden of this operative treatment. The patients are monitored with a pulmonary catheter, and blood samples for coagulation, fibrinolysis, complement and cytokine response are withdrawn pre-, per- and postoperatively. The study is partly randomized 1)where delayed intramedullary nailing is compared with primary nailing of the femur, and 2) a new reaming technique (RIA) is compared with a standard reaming technique (TR).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2003

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2003

Completed
6.7 years until next milestone

First Submitted

Initial submission to the registry

January 4, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 5, 2010

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
Last Updated

December 1, 2016

Status Verified

April 1, 2002

Enrollment Period

8.4 years

First QC Date

January 4, 2010

Last Update Submit

November 30, 2016

Conditions

Keywords

intramedullary reaminginflammatory responsehumanfemoral shaft fractureReamer-irrigator-aspirator

Outcome Measures

Primary Outcomes (2)

  • cardiopulmonary alterations

    the first three postoperative days

  • coagulation, fibrinolytic and cytokine response

    pre-, per- and first 3 days postoperatively

Secondary Outcomes (1)

  • fracture healing

    1 year

Study Arms (2)

1) IMN and EF/IMN

ACTIVE COMPARATOR

Two parts of the study are randomized; 1)initial intramedullary reaming and primary external fixation with secondary intramedullary nailing

Procedure: the effect of delayed intramedullary reaming

2) TR and RIA

ACTIVE COMPARATOR

Two parts of the study are randomized; 2)traditional reaming (TR)is compared to a new reaming device, RIA, which is a reamer connected to suction and flushing for prevention of increased intramedullary pressure

Procedure: the reaming of the femoral canal is performed with two different reaming devices

Interventions

in one group intramedullary reaming and nailing is performed immediately, femoral fractures in the second group are external fixated and than secondary nailed.

1) IMN and EF/IMN

the reaming of the femoral canal is performed with two different reaming devices; a traditional reamer (TR)and the reamer-irrigator-aspirator (RIA)

2) TR and RIA

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • femoral shaft fracture suitable for intramedullary nailing
  • \< 24 hours postinjury

You may not qualify if:

  • previous fracture of the femur
  • pathological fracture
  • femur deformities
  • pregnancy
  • previous intramedullary nailing or external fixation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Orthopedic Center, Ullevål University Hopspital

Oslo, 0407, Norway

Location

MeSH Terms

Conditions

Systemic Inflammatory Response Syndrome

Condition Hierarchy (Ancestors)

InflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Olav Røise, MD

    Orthopedic Centre, Ullevaal University Hospital, Oslo, Norway

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 4, 2010

First Posted

January 5, 2010

Study Start

May 1, 2003

Primary Completion

October 1, 2011

Study Completion

May 1, 2012

Last Updated

December 1, 2016

Record last verified: 2002-04

Locations